Diffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissue…
Biotechnology
US, Charlottesville [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Diffusion Pharmaceuticals Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDDiffusion Pharmaceuticals Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Diffusion Pharmaceuticals Inc..
If you want to see a demo, head over to the financial segments of AAPL